OptimizeRx(OPRX) - 2025 Q4 - Earnings Call Transcript

OptimizeRx (NasdaqCM:OPRX) Q4 2025 Earnings call March 05, 2026 04:30 PM ET Company ParticipantsAndy D'Silva - Chief Business OfficerDavid Grossman - Managing DirectorEdward Stelmakh - Chief Financial and Strategic OfficerJeff Garro - Managing DirectorRyan Daniels - Group Head–Healthcare Technology and ServicesSteve Silvestro - CEOConference Call ParticipantsConstantine Davides - Managing Director and Senior Equity AnalystEric Martinuzzi - Senior Research AnalystOperatorGood afternoon, everyone, thank you f ...